PeopleBio, Inc. (KOSDAQ:304840)

Market Cap	36.27B
Revenue (ttm)	3.13B
Net Income (ttm)	-9.10B
Shares Out	21.17M
EPS (ttm)	-418.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	124,369
Average Volume	119,261
Open	1,804.00
Previous Close	1,743.00
Day's Range	1,756.00 - 1,819.00
52-Week Range	1,517.00 - 6,090.00
Beta	0.54
RSI	40.34
Earnings Date	Nov 14, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Employees: 47
• Stock Exchange: KOSDAQ
• Ticker Symbol: 304840

Financial Performance

In 2024, PeopleBio's revenue was 3.73 billion, a decrease of -16.20% compared to the previous year's 4.45 billion. Losses were -10.91 billion, -31.94% less than in 2023.